No constipation | Functional constipation | |
OR (95% CI) | ||
Wheezing | ||
Unadjusted | Reference | 1.17* (1.02 to 1.32) |
Model 1 | Reference | 1.16* (1.01 to 1.31) |
Model 2 (body mass index) | Reference | 1.16* (1.01 to 1.32) |
Model 3 (infection exposure and use of antibiotics) | Reference | 1.10 (0.96 to 1.25) |
Model 4 (food allergy and infant nutrition) | Reference | 1.15* (1.01 to 1.32) |
Model 5 (parental stress) | Reference | 1.14* (1.00 to 1.30) |
Eczema | ||
Unadjusted | Reference | 1.08 (0.94 to 1.23) |
Model 1 | Reference | 1.04 (0.91 to 1.18) |
Model 2 (body mass index) | Reference | 1.04 (0.91 to 1.18) |
Model 3 (infection exposure and use of antibiotics) | Reference | 1.04 (0.91 to 1.19) |
Model 4 (food allergy and infant nutrition) | Reference | 1.03 (0.60 to 1.18) |
Model 5 (parental stress) | Reference | 1.03 (0.90 to 1.18) |
Model 1, baseline model adjusted for age, gender, mothers educational level, ethnicity, birth weight, gestational age, maternal smoking and family history of atopy; Model 2, model 1+ adjustment for body mass index; Model 3, model 1+ adjustment for history of respiratory-tract- or gastrointestinal infections in past year and daycare attendance in first 2 years of life, and use of antibiotics in the previous year; Model 4, model 1+ adjustment for history of food allergy, breast-feeding duration and introduction of food allergens ≤6 months; Model 5, model 1+ parental stress.
↵* p<0.05.